Replimune Group to Present at J.P. Morgan Healthcare Conference

Replimune +6.24%

Replimune

REPL

8.09

+6.24%

Replimune Group Inc., a clinical stage biotechnology company focused on developing novel oncolytic immunotherapies, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2025, at 1:30 PM PT. A simultaneous webcast of the presentation will be available on the Investors section of the company's website, with a replay accessible for 30 days following the event.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9604168-en) on December 18, 2025, and is solely responsible for the information contained therein.
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.